1 se RNA of CYP79D1 and CYP79D2, Siritunga and Sayre obtained several lines with a reduction level vary

2 O disease, while three (12%) of them a Kearn-Sayre syndrome (KSS).

3 progressive external ophthalmoplegia, Kearns Sayre syndrome, or Pearson's syndrome.

4                                       Kearns-Sayre syndrome (KSS) is a sporadic multisystem disorder

5 tating multi-system syndromes such as Kearns-Sayre syndrome.

6 with three major clinical conditions: Kearns-Sayre syndrome, a multisystem disorder; Pearson syndrome

7                          For example, Kearns-Sayre syndrome is caused by a single heteroplasmic mtDNA

8 t renal (tubular) tissues, such as in Kearns-Sayre and Leigh syndromes.

9 2,532-bp deletion of the type seen in Kearns-Sayre syndrome as well as a heteroplasmic A3243G mutatio

10 ost mtDNA-related diseases, including Kearns-Sayre syndrome, are recessive, only a few wild-type mtDN

11  A 35-year-old woman with features of Kearns-Sayre syndrome consisting of progressive ptosis, ophthal

12 ochondrial DNA (mtDNA) cause sporadic Kearns-Sayre syndrome, a fatal multisystem disorder, in which t

13 isorder brain, at levels greater than Kearns-Sayre Syndrome muscle.

14 acterised by a complex phenotype; the Kearns-Sayre syndrome, for example, can include cardiac abnorma

15 itochondrial genomes of patients with Kearns-Sayre or Pearson syndromes, certain ophthalmic myopathie

16       Mitochondria from patients with Kearns-Sayre syndrome harboring large-scale rearrangements of h

17                C., Sagong, B., Famenini, S., Sayre, J., Montoya, D., Rubbi L., Pellegrini, M., Fiala,

18 o-dimensional basis was then extended by the Sayre equation into three dimensions by assigning a phas